Patent · US Active

Growth differentiation factor 15 (GDF-15) polypeptides

US9714276B2 · kind B2 · utility

15Cited by
5References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 28, 2013
Grant dateJul 25, 2017
Priority date
Expiry dateMay 6, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

GDF15 polypeptides, constructs comprising GDF15, and mutants thereof are provided. In various embodiments the GDF15 polypeptides, constructs comprising GDF15, and mutants thereof, can be of use in the treatment or ameliorating a metabolic disorder. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.